Respiratory Failure Flashcards

(168 cards)

1
Q

Respiratory failure

A

Failure of gas exchange - inability to maintain normal blood gases
Low PaO2 (with or without rise in PaCO2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Respiratory failure blood gases: PaO2

A

<8 KPa
<60 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Respiratory failure blood gases: PaCO2

A

> 6.5 KPa
49 mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sea level PiO2

A

100 KPa x 0.21 = 21 KPa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Normal range PaO2

A

10.5-13.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Normal range PaCO2

A

4.7-6.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acute respiratory acidosis secondary to opiate overdose treatment

A

IV fluids
Supportive care
Opiate antagonists

Possible need for non invasive or invasive ventilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Type 1 respiratory failure: PaO2

A

Low (hypoxaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Type 1 respiratory failure: PaCO2

A

Low/ normal (hypocapnia/normal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Type 2 respiratory failure: PaO2

A

Low (hypoxaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type 2 respiratory failure: PaCO2

A

High (Hypercapnia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acute respiratory failure

A

Rapidly
Eg opiate overdose, trauma, pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Chronic respiratory failure

A

Over a period of time
Eg COPD, fibrosing lung disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes of type 1 respiratory failure

A

Most pulmonary and cardiac produce type 1 failure
Eg
infection = pneumonia, bronchiectasis
Congenital = cyanotic congenital heart disease
Neoplasm = lymphangitis carcinomatosis
Airway = COPD, asthma
Vasculature = pulmonary embolism, fat embolism
Parenchyma = pulmonary fibrosis, pulmonary oedema, pneumoconiosis, sarcoidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Causes of hypoxia

A

Mismatching of ventilation and perfusion
Shunting
Diffusion impairment
Alveolar hypoventilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Similar effects on tissue as type 1 failure as seen with

A

Anaemia
Carbon monoxide poisoning
Methaemoglobinaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Hypoxia

A

A reduced level of tissue oxygenation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hypoxaemia

A

A decrease in the partial pressure of oxygen in the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hypopnoeic

A

Slow respiratory rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Type 1 respiratory failure treatments

A

Airway patency
Oxygen delivery
Many differing systems
Increasing FiO2

Primary cause (eg antibiotics for pneumonia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Type 2 respiratory failure mechanisms

A

Lack of respiratory drive
Excess workload
Bellows failure
Increased resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Type 2 respiratory failure types

A

Airway = COPD, asthma, laryngeal oedema, sleep apnoea syndrome
Drugs = suxamethonium (paralysis)
Metabolic - poisoning, overdose
Neurological = central, primary hypoventilation, head and cervical spine injury
Muscle = myasthenia
Polyneuropathy = poliomyelitis
Primary muscle disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Clinical features of hypoxia

A

Central cyanosis
- may not be obvious in anaemia patients
-Oral cavity
Irritability
Reduced intellectual function
Reduced consciousness
Convulsions
Coma
Death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the common cause of type 1 and 2 respiratory failure

A

COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Clinical features of Hypercapnia
Variable patient to patient Irritability Headache Papilloedema Warm skin Bounding pulse Confusion Somnolence (tiredness/sleepy) Coma
26
Treatments of type 2 respiratory failure
Airway patency Oxygen delivery Primary cause (eg antibiotics for pneumonia) Treatment with O2 may be more difficult eg COPD rely on hypoxia to stimulate respiration
27
Assisted ventilation types
Invasive (facial mask) and non invasive (endotracheal tube)
28
Assisted ventilation type 2 respiratory failure
Inadequate PaO2 despite increasing FiO2 Increasing PaCO2 Patient tiring
29
Where to look for cyanosis
Under tongue
30
Oxygen treatments
5-10 litres/min face mask or 2-6 litres/min nasal cannulae Aim for SpO2 of 94-98% If saturation <85% and not at risk of hypercapnic respiratory failure 10-15 litres / minute reservoir mask Patients with COPD and other risk factors for hypercapnia; Aim for SpO2 of 88-92% pending blood gases Adjust to SpO2 of 94-98% if CO2 normal unless previous history of high CO2 or ventilation
31
Common causes of acute type 1 respiratory failure
Pneumonia Asthma
32
Common causes of acute type 2 respiratory failure
Overdose Trauma
33
Common causes of chronic type 1 respiratory failure
Fibrosing lung disease
34
Common causes of chronic type 2 respiratory failure
COPD neuromuscular
35
Why must you be cautious giving oxygen to type 2 respiratory failure
Patients have a new baseline due to habituation (normal level is hypoxaemia) Giving oxygen will get rid of drive to breathe Also, will change V/Q ratio due to reduced hypoxia related arterial vasoconstriction
36
Ageusia
Loss of taste
37
What range of values for SpO2 should aim for
94-98%
38
Rate of oxygen delivery for face mask
5-10 L/min
39
Rate of oxygen delivery for nasal cannulae
2-6 L/min
40
Rate of oxygen delivery for reservoir mask
10-15 L/min If saturation <85% and not at risk of hypercapnic respiratory failure
41
Aim for SpO2 for Patients with COPD and other risk factors for hypercapnia
88-92 % pending blood gases 94-98% if CO2 normal unless previous history of high CO2 or ventilation
42
Mask
Controlled oxygen therapy Known FiO2
43
Nasal prongs
Uncontrolled oxygen delivery More stable patients Unknown FiO2- pockets of high FiO2 develop in nasopharynx
44
Respiratory alkalosis
During hyperventilation, large volume of CO2 lost—> as CO2 is acidic causes blood to become more alkaline (raising pH) To compensate for loss of CO2, kidneys begin to secrete alkaline HCO3- into the urine in exchange for H+ ions
45
How does emphysema affect functional residual capacity
Increases due to reduced elastic recoil of lung tissue due to reduced elastic tissue
46
What are patients with chronic CO2 retention reliant on for control of ventilation
Hypoxic drive
47
Workplace causes of asthma- High molecular allergens:
Grain Wood Laboratory Animals Fish Latex Enzymes
48
Workplace causes for asthma- low molecular allergens:
Glutaraldehyde Isocyanates Paints metal working fluids Metals Chemicals Sterilising agents
49
Asthma
common chronic inflammatory disease of the airways characterized by variable and recurring symptoms reversible airflow obstruction and bronchospasm. common symptoms include wheezing, coughing, chest tightness, and shortness of breath
50
Common symptoms of asthma
wheezing, coughing, chest tightness, and shortness of breath
51
Prevalence of asthma
5-16% of people worldwide have asthma Wide variation between countries Increase in prevalence second half of the 20th century Now plateaued mostly US study; Poorer individuals, African-Americans Many studies identify a wide range of risk factors Hygiene hypothesis, Berlin
52
Asthma pollens
Emergency attendances Atlanta Poaceace (grass) and Quercus (oak) species investigated Levels associated with emergency room attendances Oak pollens particularly important in children aged 5-17 years old Australian thunderstorm data
53
Proportion of asthma caused by workplace environment
15-20%
54
Asthma infectious agents and microorganisms
Farm life protected the subsequent development of asthma Early and in utero life seem to have an important role Specific agents not identified, but likely to be a mix of bacterial and other agents, potentially altering gastrointestinal immune response Airway bacteria may also play a role in causing asthma, role of rhinovirus
55
Asthma fungi
Important roles in the development of allergic illnesses Birth cohort study Development and severity of asthma @ 7 years Children’s home sampling aged 8 months 24% had asthma aged 7 Associations with fungal exposure (aspergillus and penicillium) and subsequent asthma
56
Asthma pets
Cat ownership and exposure most implicated Exposure at home is associated with sensitisation as judged by IgE, but; Timing and intensity to pet exposures appear important
57
Asthma air pollution
Air pollution; aggravating lung diseases; Responses to pollutants can be analogous to viral responses Asthma hospitalisations relate to PM2.5 and PM10 Air pollution; inducing allergy less clear Swedish birth cohort study NO exposure in the first year of life related to pollen sensitisation at 4 years old Increasing evidence
58
Asthma peak flow
Variable
59
Hypersensitivity pneumonitis
is an inflammation of the alveoli within the lung caused by hypersensitivity to inhaled agents Acute, sub acute and chronic forms (fibrotic, non fibrotic) Immune complex related disease Antigen reacts with antibody Normally IgG response Very significant environmental influences; farmers lung, bird fanciers lung, metal working fluids
60
Hypersensitivity pneumonitis causes
Farmers lung (eg animals, mouldy straw and hay) Bird fanciers lung Metal working fluids Musical instruments Microbiological and chemical agents from the environment and work place
61
Hot tub lung
Hot tub use in general identified as a cause of EAA (hypersensitivity pneumonitis) One of the first descriptions; 1997 (Kahana et al 1997) Two recent cases of HP Case of a 49 year old male, 2 months of fever, weight loss, shortness of breath and cough Regular hot tub use Sputum grew Mycobacterium fortuitum The hot tub drain and shower drain swabs were smear positive, with cultures demonstrating M fortuitum Re-presented with further problems 2 months later, and admitted a relapse of his ban on hot tubs
62
COPD
type of obstructive lung disease characterized by chronically poor airflow. It typically worsens over time, with the main symptoms include: shortness of breath, cough, and sputum production
63
COPD causes
Tobacco smoking main cause (contains cadmium) Other causes include occupational exposures such as; Silica, Coal, Grain, Cotton, Cadmium PAH, Isocyanates, Iron/steel processing, Agricultural dust, biomass fuels, Wood dust
64
Infection
Lungs susceptible to infection from inhaled microbiological agents (i) bacteria [e.g. pseudomonas], viral [e.g. COVID-19]
65
Percentage of COPD caused by occupational exposures
10-15%
66
Which metal exposure is associated with emphysema development
Cadmium
67
What metal causes asthma
Chromium
68
Important COPD occupational exposures
Silica Coal Grain cotton Cadmium
69
Asbestos exposure associated conditions
Pleural plaques Pleural thickening Benign pleural effusions Asbestosis Lung cancer Malignant mesothelioma
70
Effects of hypersensitivity pneumonitis
Regional variation in the lung Inflammation of bronchioles
71
Silicosis
Turkish denim sandblasters
72
Low lung function growth trajectory due to
Genetics Preterm birth Early life environmental exposures LRTI Childhood persistent asthma
73
Asthma and genes
Asthma runs in families Children of asthmatic parents are at increased risk of asthma Asthma is not caused by a single mutation in one gene Transmission of the disease through generations does not follow simple Mendelian inheritance typical of classic monogenic diseases New genotyping technologies has made it possible to sequence the human genome for asthma-associated variants
74
Asthma personalised medicine
Individualise pharmacotherapy based on genetic polymorphisms Certain drugs are administered only to those patients who are most likely to respond Harmful effects are avoided in patients who are most likely to experience toxicity and adverse reactions Candidate genes for such studies are those encoding receptor proteins and enzymes involved in drug transportation, processing, degradation and excretion.
75
Cystic fibrosis
Chronic genetic disease Multi-organ involvement In UK >10,000 people affected Median age of death improving Most common lethal autosomal recessive genetic disorder in Caucasians Static incidence with an increasing prevalence
76
Cystic fibrosis genes
Defect in long arm of chromosome 7 coding for the cystic fibrosis transmembrane regulator (CFTR) protein (anion channel) >1600 mutations of CFTR gene identified 90% within a panel of 70 mutations F508del most common mutation causing CF
77
Proportion of carriers of cystic fibrosis
1:25
78
CTFR protein
Transport protein on membrane of epithelial cells Abnormal CFTR protein leads to dysregulated epithelial fluid transport 80% Lung and gastrointestinal involvement 15% Lung alone
79
Pathophysiology - cystic fibrosis
Bronchitis —> bronchiectasis —>fibrosis
80
Cystic fibrosis diagnosis
Genetic profile and neonatal screening (day 5 IRT) Clinical symptoms – frequent infections, malabsorption, failure to thrive Abnormal salt / chloride exchange – raised skin salt Late diagnoses via infertility services – azoospermia or via gastroenterology team with recurrent pancreatitis / malabsorption 50% diagnosed @ 6 months 90% diagnosed @ 8 years of age
81
What percentage of patients with cystic fibrosis diagnosed at 6 months
50%
82
What percentage of patients with cystic fibrosis diagnosed at 8 years
90%
83
CF respiratory symptoms
Persistent cough with productive thick mucus Wheezing and shortness of brewth]frequent chest infections Sinusitis Nasal polyps
84
CF digestive symptoms
Bowel disturbances Weight loss Obstructive Constipation
85
CF MSK symptoms
Osteoporosis Arthritis
86
Prevalence of CF
1 in 2500
87
CF reproductive symptoms
95% men and 20% women are infertile
88
Normal lung function growth trajectory
FEV1 increases to 100% as you age up until mid-20s as lungs are still growing Lung function then plateaus and begins to decrease
89
CF pathophysiology : in the pancreas
blockage of exocrine ducts, early activation of pancreatic enzymes, and eventual auto-destruction of the exocrine pancreas Most patients require supplemental pancreatic enzymes
90
Asthma inheritance
Does NOT follow Mendelian inheritance But runs in families
91
CF pathophysiology : in the intestine
Bulky stools can lead to intestinal blockage
92
CF pathophysiology : in the respiratory system
mucus retention, chronic infection, and inflammation that eventually destroy lung tissue There are multiple hypotheses regarding the pathogenesis of lung disease, each of which is supported by data in vitro and in vivo Lung disease is the most common cause of morbidity and mortality
93
Which chromosome codes for CFTR protein
Long arm of chromosome 7 7q
94
Most common mutation causing CF
F508del 2 abnormal genes
95
Number of CFTR gene mutations identified
>1600
96
Mutant CFTR channels
Does not move Cl-, causing sticky mucus to build up on the outside of the cell Leads to dysregulated epithelial fluid transport
97
The vicious cycle
Respiratory tract infection (microbial insults OR defect in host defence) —> bronchial inflammation—> respiratory tract damage —> more liable onto infection… Progressive lung disease
98
Clinical symptoms cystic fibrosis diagnosis
Frequent infections Malabsorption Failure to thrive
99
Abnormal salt/chloride exchange
A mild electrical current pushes medicine into skin to cause sweating Sweat is collected and salt content measured
100
CF general treatment strategy
Maintenance and prevention management Rescue Personalised approaches
101
CF prevention management
Segregation Surveillance- frequent reviews minimum every 3 months Airway clearance- physio and exercise Nutrition- pancreatic enzymes, diet high calorie and fat, supplements including vitamins, percutaneous feeding Psychosocial support
102
CF geneotype classification
Class I: no functional CFTR protein is made (e.g. G542X) Class II: CFTR protein is made but it is mis-folded (e.g. F508del) Class III: CFTR protein is formed into a channel but it does not open properly (e.g. G551D) Class IV: CFTR protein is formed into a channel but chloride ions do not cross the channel properly (e.g. R347P) Class V: CFTR protein is not made in sufficient quantities (e.g. A455E) Class VI: CFTR protein with decreased cell surface stability (e.g. 120del123) More than 2000 CF - causing CFTR mutations have been found Most common of which is F508del [a class II mutation found in up to 80% to 90% of patients]
103
Classes of CF
Different classes of genotype abnormality for development of CTFR protein Class I- Class VI
104
CF medications
Suppression of chronic infections – antibiotic nebulisation Bronchodilation – salbutamol nebulisation Anti inflammatory – azithromycin, corticosteroids Diabetes – insulin treatment Vaccinations – influenza, pneumococcal, SARS CoV 2
105
CF rescue antibiotics
2 week course IV antibiotics Home vs hospital Issues with frequent antibiotics Allergies Renal impairment Resistance Access problems
106
Issues with frequent antibiotics
Allergies Renal impairment Resistance Access problems
107
CF personalised approaches
Individual tailored or targeted medicine Move away from a ‘one size fits all’ approach Stratified based on predicted response or risk of disease Genetic information major factor Monogenic disorder (i.e. is the result of mutation(s) in a specific gene) Well-characterised pathophysiology with clear therapeutic targets Genotype directed therapies Targeted treatments based on infectious organisms and resistance patterns
108
Ivacaftor (kalydeco)
CFTR potentiator- potentiates chloride secretion via increased CFTR channels opening time Class III mutations
109
Lumacaftor (orkambi)
CFTR corrector - corrects cellular misprocessing of CFTR (e.g. folding) to facilitate transport from the endoplasmic reticulum Class II mutation - F508del/F508del
110
CF phage therapies
Bacteriophage therapy is the use of lytic phases to kill infectious diseases
111
Challenges treating CF
adherence to treatment High treatment burden High cost of certain treatments Allergies/intolerances to treatment Different infectious organisms and resistance to drugs
112
Alpha-1 antitrypsin deficiency (AATD)
Autosomal recessive genetic disorder 80 different mutations of SERPINEA1 gene on chromosome 14 Serum antiprotease M phenotype normal and healthy S and Z phenotypes major disease associations
113
Which gene is mutated AATD
SERPINEA1 gene on chromosome 14
114
AATD M phenotype
Normal and healthy PiMM
115
AATD S and Z phenotypes
Major disease associations
116
Consequences of AATD
Early onset emphysema (proteases in lung breakdown lung proteins) and bronchiectasis Liver cirrhosis Unopposed action of neutrophil elastase in the lung
117
Flat diaphragm
Sign of emphysema
118
Dyspnoea
Sense of awareness of increased respiratory effort Inappropriate
119
Orthopnoea
Breathless on lying down
120
Tachypnoea
Increased respiratory rate
121
Bradypnoea
Reduced respiratory rate
122
Hyperventilation
Inappropriate over breathing
123
Paroxysmal nocturnal dyspnoe
Episodes of shortness of breath
124
Genetic inheritance of asthma
Is not caused by a single mutation (at least chromosome 2,6,9,15,17 and 22 are involved)
125
Type I respiratory failure
• involves low oxygen, and normal or low carbon dioxide levels. (hypoxaemia (PaO2 <8 kPa / 60mmHg) with normocapnia (PaCO2 <6.0 kPa / 45mmHg)) • It usually occurs due to ventilation/perfusion (V/Q) mismatch – the volume of air flowing in and out of the lungs is not matched with the flow of blood to the lung tissue • As a result of the ventilation/perfusion mismatch, PaO2 falls, and PaCO2 rises. The rise in PaCO2 rapidly triggers an increase in a patient’s overall alveolar ventilation, which corrects the PaCO2 but not the PaO2 due to the different shapes of the CO2 and O2 dissociation curves.
126
Entire lung failure…
Type II respiratory failure
127
COPD and type II respiratory failure
COPD causes habituation of high PaCO2 Begin to rely on low PaO2 for drive to breathe
128
What causes the drive to breathe
PaCO2 Small changes causes difference as very sensitive
129
Type II respiratory failure flow diagram
Hypoventilation —> increase PCO2 (acidic) —> increase H2CO3 —> decrease pH Respiratory acidosis
130
Acute phase of type II respiratory failure
CO2 moving into RBCs combines with H2O- carbonic anhydride converts to H2CO3 which dissociates into HCO3 -
131
Chronic phase of type II respiratory failure
Renal: Increased HCO3 - reabsorption Increased H+ excretion in ammonia (NH3+ -> NH4)
132
Causes of decreased pH (metabolic acidosis)
Renal failure GI HCO3 - loss eg cholera Diabetic ketoacidosis Dilution of blood with H2O Failed H+ excretion (hypoalosteronism)
133
Metabolic acidosis pathway
Decreased pH—> chemoreceptors increase respiratory rate —> decreases PCO2 —> decreases H2CO3
134
Causes of increased pH (metabolic alkalosis)
Vomiting (HCL loss) Alkali ingestion Renal acid loss: hyperaldosteronism, hyperkalaemia
135
Metabolic alkalosis pathway
Increased pH —> chemoreceptor inhibition —> decrease’s respiratory rate- hypoventilation—> increases PCO2 —> decreases pH
136
Type I respiratory failure flow diagram
Hyperventilation—> decreases PCO2 (acidic) —> decreases H2CO3 —> increases pH Respiratory alkalosis
137
Chronic type I respiratory failure
Renal: Decreased HCO3 - reabsorption Decreased H+ excretion
138
Gaseous diffusion impairment
Pulmonary oedema
139
Blood diffusion impairment
Anaemia
140
Membrane diffusion impairment
Interstitial fibrosis
141
Complete airway blockage
Shunt V/Q= 0
142
Partial airway blockage
Decreased V/Q Local hypoxia
143
Complete blood blockage
V/Q = infinty
144
Partial blood blockage
Increased V/Q
145
What is V/Q mismatch counteracted by
Local Bronchoconstriction Hypoxic pulmonary vasoconstriction (weak-little muscle) diverts blood to better-oxygenated lung segments
146
FeNO (fractional expired nitric oxide)
Marker of eosinophilic airway inflammation >50 ppb
147
Chronic bronchitis
Inflammation Increased mucus
148
Emphysema
Decreased lung surface area Destruction of alveoli and capillaries Decreased elastic recoil Distended thorax (barrel chest)
149
Class 2 CF
Misfolded CFTR Eg F508del (most common)
150
Class 3 CF
CFTR channel doesn’t open properly
151
Treatment of AATD
Antiproteases inhibit neutrophil elastase from damaging elastin
152
which is the most clinical significant form of alpha 1 anti trypsin deficiency
PiZZ
153
A 67 year old patient is being investigated for shortness of breath. Which of the following conditions would normally lead to Type 2 Respiratory Failure?
Increased airways resistance - chronic obstructive pulmonary disease Reduced breathing effort (drug effects, brain stem lesion, extreme obesity) A decrease in the area of the lung available for gas exchange (such as in chronic bronchitis) Neuromuscular problems
154
70 year old has an X-ray to investigate their shortness of breath. It reveals a suspicious lesion associated with the pleura. What is the term used to describe a malignant tumour of the pleural membranes?
Mesothelioma
155
An 83 year old patient is admitted with shortness of breath and is diagnosed with Type 1 respiratory failure. Which of the following arterial blood gas results characterizes Type 1 Respiratory Failure?
low pO2, normal/low pCO2
156
A 67 year old patient is being investigated for shortness of breath. Which of the following arterial blood gas results is typical of chronic Type 2 Respiratory Failure?
low pO2, high pCO2, normal-high HCO3-
157
type 1 respiratory failure is caused by conditions that affect oxygenation such as:
Low ambient oxygen (e.g. at high altitude) Ventilation-perfusion mismatch (parts of the lung receive oxygen but not enough blood to absorb it, e.g. pulmonary embolism) Alveolar hypoventilation due to reduced respiratory muscle activity, e.g. in acute neuromuscular disease (this form can also cause type 2 respiratory failure if severe) Diffusion problem (oxygen cannot enter the capillaries due to parenchymal disease, e.g. in pneumonia) Shunt (oxygenated blood mixes with non-oxygenated blood from the venous system, e.g. right to left shunt)
158
A 5 year old is scheduled for theatre to remove an inhaled peanut. Where is the inhaled peanut most likely to become lodged in their airway?
Right main bronchus
159
In chronic hypercapnia, which pathway controls respiratory drive
Chemoreceptors in the carotid bodies detect low blood oxygen and send signals via cranial nerves to the dorsal respiratory group. Motor output is sent via the phrenic nerve to stimulate contraction of the diaphragm and increase respiratory rate
160
Chronic hypercapnia and respiratory drive
Central chemoreceptors in dorsal medulla less able to respond to carbon dioxide levels Body becomes reliant on peripheral chemoreceptors and hypoxic drive
161
Respiratory acidosis blood gases
PaO2 <8 KPa PaCO2 > 6KPa
162
What is the effect of a marked increase in pulmonary capillary pressure in lung compliance
Decrease in compliance as pulmonary oedema occurs
163
How does emphysema affect lung compliance
Increases due to loss of elastic tissue
164
How does pulmonary fibrosis affect lung compliance
Decrease
165
Flapping tremor/ asterixis
Sign of CO2 retention - type 2 respiratory failure
166
Shallow breathing leads to
Respiratory acidosis
167
Hyperventilating leads to
Respiratory alkalosis
168
Joe is a 50 year old man who has just returned to Blackburn after living in Thailand for a year. Over the next few days he notices that he’s finding it more difficult to breathe, and that when he does he feels a sharp pain. He goes to his GP who diagnoses him with a pulmonary embolism. What is the main kind of hypoxia that a pulmonary embolism would cause
V/Q mismatch